tiprankstipranks
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
PremiumPress ReleasesBiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
1M ago
BiomX files to sell 120.15M warrants to buy common stock for holders
PremiumThe Fly
BiomX files to sell 120.15M warrants to buy common stock for holders
2M ago
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
PremiumPress Releases
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
2M ago
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
PremiumPress ReleasesBiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
2M ago
BiomX announces compliance with NYSE guidelines on audit opinion disclosure
PremiumThe Fly
BiomX announces compliance with NYSE guidelines on audit opinion disclosure
2M ago
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3M ago
BiomX Merger and Strategic Equity Deals Reshape Future
PremiumCompany AnnouncementsBiomX Merger and Strategic Equity Deals Reshape Future
3M ago
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
PremiumPress Releases
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
3M ago
BiomX enters merger agreement with Adaptive Phage Therapeutics
PremiumThe Fly
BiomX enters merger agreement with Adaptive Phage Therapeutics
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100